User banner image
User avatar
  • admin

Posts

On The Tenth Anniversary of Its Debut, Michter’s is Releasing Its US*1 Toasted Barrel Finish Bourbon Once Again

LOUISVILLE, Ky., Aug. 13, 2024 /PRNewswire/ — Louisville-based Michter’s will begin shipping its 2024 bottling of its US*1 Toasted Barrel Finish Bourbon in September. With its...

LBB Specialties Expands into Puerto Rico and Latin America to Serve Growing Life Sciences Market

NORWALK, Conn., Aug. 13, 2024 /PRNewswire/ — LBB Specialties (LBBS), a leading North American distributor of specialty chemicals and ingredients, today announced its strategic expansion...

GIGABYTE OLED Gaming Monitors Win Red Dot Design Award and Receive Media Acclaim

TAIPEI, Aug. 13, 2024 /PRNewswire/ — GIGABYTE, the world’s leading computer brand, is proud to announce the outstanding achievements of its latest OLED gaming monitors. The...

Probiotic Cosmetics Market Global Forecast Report 2024-2029: L’Oreal Group Aim to Increase the Use of Natural Ingredients by 95% and Become the Global Industry Leader by 2030

Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) — The “Probiotic Cosmetics Market – Global Outlook & Forecast 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The...

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Phase 3 Orbit and Cosmic studies of setrusumab in OI, conducted by our partner Ultragenyx, fully enrolled New long-term Phase 2 data from the Phase...

Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results

GIMOTI second quarter net product sales grew 47% quarter-over-quarter and 126% year-over-year, indicating an annual run-rate in excess of $10 million Achieved record-high prescription fills...

Notice of Nexstim Plc’s Half-Year Report H1 2024

Press release, Helsinki, 13 August 2024 at 3 PM (EEST) Notice of Nexstim Plc’s Half-Year Report H1 2024 Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) will...

Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

Published data show that responses from 1-month and 24-hour recall patient reported outcome (PRO) instruments were similar and support that either method could be used...

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update

NAVIGATE trial on track for interim top-line analysis in December 2024 NORCROSS, Ga., Aug. 13, 2024 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the...

Personal Luxury Goods Market Global Forecast Report 2024-2028: Surging Millennial Spending and Flourishing Second-Hand Personal Luxury Goods Market Drives Growth – A S$443.80 Billion Market by 2028

Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) — The “Personal Luxury Goods Market by Product, Sales Channel, End-User & Region: Insights & Forecast (2024-2028)” report has...